388 filings
Page 14 of 20
8-K
xgw2 uqr5q2ndcv53zt5
25 Feb 16
Results of Operations and Financial Condition
12:00am
8-K
y9lzvlne3wi05
21 Jan 16
Alkermes Announces Topline Results of FORWARD-3 and FORWARD-4, Two Phase 3 Studies of Alks 5461 In Major Depressive Disorder
12:00am
CT ORDER
gqv9zoci6i
11 Jan 16
Confidential treatment order
12:00am
8-K
4bq80
29 Oct 15
Alkermes PLC Reports Third Quarter 2015 Financial Results
12:00am
8-K
xkd61 fu87
16 Oct 15
Regulation FD Disclosure
12:00am
8-K
czewnwejmwvgf5e
6 Oct 15
Fda Approves Aristada™ for Treatment of Schizophrenia
12:00am
8-K
zbi9colm1ep oso3dzsq
21 Aug 15
Alkermes Provides Update on Fda Review of Aristada™ for the Treatment of Schizophrenia
12:00am
CT ORDER
0jhjrg ofuxbdb
18 Aug 15
Confidential treatment order
12:00am
8-K
grcpmk0znbg5dx
30 Jul 15
Alkermes PLC Reports Second Quarter 2015 Financial Results
12:00am
UPLOAD
y8agb0syq
20 Jul 15
Letter from SEC
12:00am
CT ORDER
rlm3l4d60c3q
7 Jul 15
Confidential treatment order
12:00am
CORRESP
xwfuskh9h
17 Jun 15
Correspondence with SEC
12:00am
UPLOAD
d3a52f
9 Jun 15
Letter from SEC
12:00am
8-K
5cyqmd3j15 yga
29 May 15
Departure of Directors or Certain Officers
12:00am
8-K
2h8wvwn6n
30 Apr 15
Alkermes PLC Reports First Quarter 2015 Financial Results
12:00am
8-K/A
7oix d0h6
16 Apr 15
Completion of Acquisition or Disposition of Assets
12:00am